Experts suggest to start screening for PCa in men with known BRCA2 and BRCA1 mutations at the age of 40 [23], supported by studies that have revealed a diagnosis of PCa at as early as 41 years of age in BRCA2- and 43 in BRCA1-mutated patients [41]. Here, BRCA2 is linked to posterior cortical atrophy.